A detailed history of Lpl Financial LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Lpl Financial LLC holds 126,086 shares of ADPT stock, worth $591,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares
126,086
Previous 136,279 7.48%
Holding current value
$591,343
Previous $493,000 30.83%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$3.37 - $5.12 $34,350 - $52,188
-10,193 Reduced 7.48%
126,086 $645,000
Q2 2024

Aug 07, 2024

BUY
$2.34 - $3.96 $67,483 - $114,202
28,839 Added 26.84%
136,279 $493,000
Q1 2024

May 10, 2024

BUY
$2.88 - $4.8 $17,887 - $29,812
6,211 Added 6.14%
107,440 $344,000
Q4 2023

Feb 14, 2024

BUY
$3.46 - $5.33 $68,373 - $105,326
19,761 Added 24.26%
101,229 $496,000
Q3 2023

Nov 13, 2023

BUY
$5.07 - $8.44 $124,159 - $206,687
24,489 Added 42.98%
81,468 $444,000
Q2 2023

Jul 31, 2023

BUY
$6.19 - $8.78 $32,522 - $46,130
5,254 Added 10.16%
56,979 $382,000
Q1 2023

May 10, 2023

BUY
$7.8 - $10.11 $27,300 - $35,385
3,500 Added 7.26%
51,725 $456,000
Q4 2022

Feb 07, 2023

BUY
$6.26 - $9.34 $27,481 - $41,002
4,390 Added 10.01%
48,225 $368,000
Q3 2022

Nov 14, 2022

SELL
$6.5 - $12.67 $1,898 - $3,699
-292 Reduced 0.66%
43,835 $312,000
Q2 2022

Aug 12, 2022

SELL
$6.4 - $14.73 $211,251 - $486,207
-33,008 Reduced 42.79%
44,127 $357,000
Q1 2022

May 16, 2022

BUY
$10.12 - $28.9 $358,794 - $1.02 Million
35,454 Added 85.06%
77,135 $1.07 Million
Q4 2021

Feb 14, 2022

BUY
$25.17 - $36.85 $73,999 - $108,339
2,940 Added 7.59%
41,681 $1.17 Million
Q3 2021

Nov 15, 2021

BUY
$30.02 - $39.87 $51,214 - $68,018
1,706 Added 4.61%
38,741 $1.32 Million
Q2 2021

Aug 13, 2021

BUY
$32.22 - $44.59 $535,367 - $740,907
16,616 Added 81.38%
37,035 $1.51 Million
Q1 2021

May 14, 2021

BUY
$37.26 - $67.74 $585,615 - $1.06 Million
15,717 Added 334.26%
20,419 $822,000
Q4 2020

Feb 12, 2021

BUY
$45.01 - $65.47 $211,637 - $307,839
4,702 New
4,702 $278,000
Q3 2020

Nov 09, 2020

SELL
$35.79 - $48.81 $692,608 - $944,571
-19,352 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$24.95 - $48.38 $482,832 - $936,249
19,352 New
19,352 $936,000
Q1 2020

May 14, 2020

SELL
$16.96 - $34.16 $451,186 - $908,758
-26,603 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$24.56 - $32.8 $653,369 - $872,578
26,603 New
26,603 $796,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.